Interferon-mediated intracellular signalling. Modulation of different phospholipase activities in Burkitt lymphoma cells

FEBS Lett. 1992 Nov 30;313(3):210-2. doi: 10.1016/0014-5793(92)81193-p.

Abstract

The effect of interferon-alpha on Daudi lymphoma cells either sensitive or resistant to the action of this cytokine has been analysed in terms of phospholipase C (PLC) and D (PLD) activities. Results have shown a combined modulation of PIP2-specific phospholipase C and phospholipase D. In particular, a decreased activity of PIP2-specific PLC has been found, concomitant to a PLD-mediated phosphatidylcholine hydrolysis, suggesting that the intracellular signalling activated by interferon in Daudi cells involves a phospholipase D/phosphohydrolase pathway.

MeSH terms

  • Burkitt Lymphoma / enzymology
  • Diglycerides / metabolism
  • Humans
  • In Vitro Techniques
  • Interferon alpha-2
  • Interferon-alpha / pharmacology*
  • Phosphatidic Acids / metabolism
  • Phospholipase D / metabolism*
  • Propranolol / pharmacology
  • Recombinant Proteins
  • Signal Transduction
  • Tumor Cells, Cultured
  • Type C Phospholipases / metabolism*

Substances

  • Diglycerides
  • Interferon alpha-2
  • Interferon-alpha
  • Phosphatidic Acids
  • Recombinant Proteins
  • Propranolol
  • Type C Phospholipases
  • Phospholipase D